Cargando…

Qualitative research on community experiences in large HIV research trials: what have we learned?

INTRODUCTION: Very few pragmatic and community‐level effectiveness trials integrate the use of qualitative research over all stages of the trial, to inform trial design, implementation optimization, results interpretation and post‐trial policy recommendations. This is despite the growing demand for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camlin, Carol S, Seeley, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192898/ https://www.ncbi.nlm.nih.gov/pubmed/30334379 http://dx.doi.org/10.1002/jia2.25173

Ejemplares similares

COVID-19 and patient engagement in health research: What have we learned?
por: Denegri, Simon, et al.
Publicado: (2021)

Mobility and HIV care engagement: a research agenda
por: Thorp, Marguerite, et al.
Publicado: (2023)

Gene expression in human sepsis: what have we learned?
por: Russell, James A
Publicado: (2011)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers
por: Simon, Caty, et al.
Publicado: (2021)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

HIV prevention: What have we learned from community experiences in concentrated epidemics?
por: Spire, Bruno, et al.
Publicado: (2008)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
por: Husain-Syed, Faeq, et al.
Publicado: (2021)

Bringing population mobility into focus to achieve HIV prevention goals
por: Camlin, Carol S, et al.
Publicado: (2018)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

Taming the Huntington’s Disease Proteome: What Have We Learned?
por: Seeley, Connor, et al.
Publicado: (2021)

One step ahead: timing and sexual networks in population mobility and HIV prevention and care
por: Cassels, Susan, et al.
Publicado: (2018)

Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?
por: Wells, Robert, et al.
Publicado: (2007)

Editorial: Research in Transgender Healthcare: What Have We Learned and Where Are We Going?
por: Fernández, Rosa, et al.
Publicado: (2022)

Targeting cytokine storm in COVID-19: what have we learned?
por: Ridker, Paul M
Publicado: (2021)

Biostatistics as a Tool for Medical Research: What are we Doing Wrong?
por: Tsiamalou, Paraskevi, et al.
Publicado: (2019)

Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?
por: Tang, Jordan, et al.
Publicado: (2011)

Estimating maternal mortality: what have we learned from 16 years of surveys in Afghanistan?
por: Alba, Sandra, et al.
Publicado: (2020)

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020)

Food safety in Vietnam: where we are at and what we can learn from international experiences
por: Nguyen-Viet, Hung, et al.
Publicado: (2017)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

Violence against children in the time of COVID-19: What we have learned, what remains unknown and the opportunities that lie ahead
por: Fore, Henrietta H.
Publicado: (2021)

Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?
por: Ewer, Michael S., et al.
Publicado: (2016)

Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
por: Mathebula, Lindi, et al.
Publicado: (2022)

Poverty, protests and pandemics: what can we learn from community resilience?
por: Ahmed, Rashid, et al.
Publicado: (2021)

The (pro)renin receptor. A decade of research: what have we learned?
por: Krop, Manne, et al.
Publicado: (2012)

Metasynthetic Madness: What Kind of Monster Have We Created?
por: Thorne, Sally
Publicado: (2016)

30 years of HIV: what have we learned?
por: Gazzard, Brian
Publicado: (2014)

Vertical interventions and system effects; have we learned anything from past experiences?
por: Oliveira, Charlotte, et al.
Publicado: (2015)

Why interventions to prevent intimate partner violence and HIV have failed young women in southern Africa
por: Mannell, Jenevieve, et al.
Publicado: (2019)

Human-centred mentorship in global health research: are we ready to give what it takes?
por: Rasheed, Muneera A, et al.
Publicado: (2023)

Community care demonstrations: What have we learned?
por: Kemper, Peter, et al.
Publicado: (1987)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

The research we have is not the research we need
por: Reeves, Thomas C., et al.
Publicado: (2020)

Thirty Years of Mungbean Genome Research: Where Do We Stand and What Have We Learned?
por: Somta, Prakit, et al.
Publicado: (2022)

Ultra-processed foods and human health: What do we already know and what will further research tell us?
por: Srour, Bernard, et al.
Publicado: (2021)

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities
por: West, Howard (Jack), et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ui7oopvd7jp1q8iju5qarnta12